ѻý

Epstein-Barr and MS; When Lewy Pathology Starts; Alzheimer's Blood Test Assessed

<ѻý class="mpt-content-deck">— News and commentary from the world of neurology and neuroscience
MedpageToday
Neuro Break over a computer rendering of neurons.

Antibody response to anti-Epstein-Barr virus nuclear antigen 1 (EBNA-1) may be a (MS), a small study suggested. (JAMA Neurology)

ND0612, a subcutaneous , increased on time without troublesome dyskinesia and reduced off time when used in combination with oral immediate-release levodopa-carbidopa in a phase III trial. (Lancet Neurology)

A forensic autopsy study showed that started in middle age. (Annals of Neurology)

Researchers showed how the brain coordinates in mice. (Science)

Risks of cerebral hemorrhage with anti-amyloid drugs like lecanemab (Leqembi) suggest a need to create for Alzheimer's disease, physicians argued. (JAMA)

From March 2020 through June 2021, people with of being hospitalized with and dying from COVID-19 than controls, a study in Wales reported. (Epilepsia)

MRI features distinguished from viral encephalitis and Creutzfeldt-Jakob disease. (JAMA Neurology)

The that combined an amyloid-beta 42/40 ratio and the percent of phosphorylated tau 217 showed an area under the curve of 0.94, yielding 88% agreement with amyloid PET. (Alzheimer's and Dementia)

Risk of was driven more by the number of years in which repetitive head impacts were experienced in contact sports -- especially American football -- than the number of traumatic brain injuries. (Neurology)

A Virginia Commonwealth University-led and other neurodegenerative diseases is poised to become state law. (Virginia Mercury)

  • Judy George covers neurology and neuroscience news for ѻý, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more.